Skip to main content
. 2015 Apr 10;18(1):19463. doi: 10.7448/IAS.18.1.19463

Table 2.

Factors associated with advanced HIV diagnosis: defined by CD4 cell count at diagnosis <200 cells/µL and or new AIDS illness within six months of HIV diagnosis

Univariate model Multivariable model

Factor Level OR (95% CI) Pa aOR (95% CI) Pa
Sex Female 0.841 (0.46, 1.45) 0.48 0.50 (0.26, 0.98) 0.04
Male 1.00 (ref) 1.00 (ref)
Age at diagnosis (years) <30 1.00 (ref) <0.01 1.00 (ref) <0.01
30–40 1.82 (1.05, 3.16) 1.73 (0.98, 3.05)
40–50 2.21 (1.27, 3.83) 2.07 (1.16, 3.68)
>50 5.73 (3.30, 9.94) 4.91 (2.74, 8.76)
Mode of probable HIV exposure MSM 1.00 (ref) <0.01 1.00 (ref) <0.01
Heterosexual 1.79 (1.29, 2.47) 2.04 (1.38, 3.02)
IDU 1.61 (0.82, 3.17) 1.96 (0.92, 4.18)
Other 2.70 (1.49, 4.88) 2.05 (1.08, 3.86)
Continental region of birth Australia 1.00 (ref) 0.02 1.00 (ref) <0.01
New Zealand/Pacific Islander 0.69 (0.25, 2.09) 0.72 (0.22, 2.20)
Africa 2.89 (1.23, 6.81) 3.87 (1.49, 10.08)
Americas 3.15 (1.18, 8.41) 2.60 (0.88, 7.70)
Asia 1.88 (1.12, 3.16) 2.57 (1.44, 4.58)
Europe 1.75 (1.02, 2.99) 1.78 (0.98, 3.21)
Not reported 1.27 (0.88, 1.82) 0.79 (0.53, 1.20)
Hepatitis B co-infection Positive 1.45 (0.69, 3.08) 0.14 1.41 (0.64, 3.15) 0.67
Negative 1.00 (ref) 1.00 (ref)
Not reported 0.73 (0.49, 1.07) 1.08 (0.64, 1.75)
Hepatitis C co-infection Positive 1.00 (0.58, 1.71) 0.27 0.99 (0.54, 1.81) 0.41
Negative 1.00 (ref) 1.00 (ref)
Not reported 0.64 (0.37, 1.10) 0.62 (0.31, 1.25)
Australian state capital city setting Capital city 1.00 (ref) 0.02 1.00 (ref) <0.01
Non-capital city 1.43 (1.06, 1.92) 2.40 (1.34, 4.31)
Primary care setting General practice 0.69 (0.50, 0.96) <0.01 1.36 (0.75, 2.45) <0.01
Hospital clinic 1.43 (1.00, 2.02) 2.88 (1.57, 5.30)
Sexual health clinic 1.00 (ref) 1.00 (ref)
Year of HIV diagnosis 1996–2000 1.00 (ref) <0.01 1.00 (ref) <0.01
2001–2006 0.46 (0.32, 0.65) 0.44 (0.31, 0.67)
2007–2012 0.72 (0.51, 1.02) 0.70 (0.48, 1.02)
a

Wald test for categorical level heterogeneity. MSM=men who have sex with men; IDU=injecting drug use.